Fluticasone propionate and montelukast, administered individually or in combination, reduce airway blood flow in asthma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1441, 2004-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Comparison of Salmeterol/Fluticasone Propionate Combination with Budesonide in Patients with Mild-to-Moderate Asthma

By Johansson G.  

Clinical Drug Investigation, Vol. 21, Iss. 9, 2001-09 ,pp. : 633-642

Adis International

Access to resources Recommend Favorite

Inhaled Salmeterol/Fluticasone Propionate Combination: A Review of its Use in Persistent Asthma

By Markham A.   Jarvis B.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1207-1233

Adis International

Access to resources Recommend Favorite

Salmeterol/Fluticasone Propionate Combination

By Spencer C.M.   Jarvis B.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 933-940

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite